Weon-Kyoo You
Head of Research & Development ABL Bio
Seminars
Tuesday 4th November 2025
Presentation Sneak Peek:
Validation of Novel Target Combination for Bispecific ADCs by Increasing Tumor Selectivity & Reducing Off-Target Toxicity
- Outlining target combination rationale for bispecific ADC design
- Assessing preclinical safety and efficacy of bispecific ADCs compared vs monospecific ADCs
- Important points to prepare for IND applications and clinical trials of bispecific ADCs
Tuesday 4th November 2025
Presentation Sneak Peek:
Validation of Novel Target Combination for Bispecific ADCs by Increasing Tumor Selectivity & Reducing Off-Target Toxicity
- Outlining target combination rationale for bispecific ADC design
- Assessing preclinical safety and efficacy of bispecific ADCs compared vs monospecific ADCs
- Important points to prepare for IND applications and clinical trials of bispecific ADCs
